英文名称：
Dabigatran etexilate Impurity T
达比加群酯杂质T(1415506-16-9)名称与标识符
达比加群酯杂质T(1415506-16-9)相关文献
- 1. A comparative study of the molecular structure, lipophilicity, solubility, acidity, absorption and polar surface area of coumarinic anticoagulants and direct thrombin inhibitors
Milan Remko,Ria Broer,Anna Remková RSC Adv. 2014 4 8072 - 2. Developing an adult stem cell derived microphysiological intestinal system for predicting oral prodrug bioconversion and permeability in humans
Abhinav Sharma,Liang Jin,Xue Wang,Yue-Ting Wang,David M. Stresser Lab Chip 2024 24 339 - 3. A comparative study on the analytical performance of a charged aerosol detector and an ultraviolet detector for the RP-LC analysis of dabigatran etexilate in capsules
Raquel M. Bernardi,Felipe B. D'Avila,Vítor Todeschini,Pedro E. Fr?ehlich,Ana M. Bergold Anal. Methods 2013 5 4777 - 4. Identification of dabigatran etexilate major degradation pathways by liquid chromatography coupled to multi stage high-resolution mass spectrometry
Fatma Amrani,Philippe-Henri Secrétan,Hassane Sadou-Yayé,Caroline Aymes-Chodur,Mélisande Bernard,Audrey Solgadi,Najet Yagoubi,Bernard Do RSC Adv. 2015 5 45068 - 5. Design, synthesis, biological evaluation and molecular docking of novel dabigatran derivatives as potential thrombin inhibitors
Chun-Lei Li,Ming-Hui Dong,Yu-Jie Ren,Li-Hua Li RSC Adv. 2015 5 23737 - 6. Discovery of AZD8165 – a clinical candidate from a novel series of neutral thrombin inhibitors
K. Abrahamsson,P. Andersson,J. Bergman,U. Bredberg,J. Br?nalt,A.-C. Egnell,U. Eriksson,D. Gustafsson,K.-J. Hoffman,S. Nielsen,I. Nilsson,S. Pehrsson,M. O. Polla,T. Skjaeret,M. Strimfors,C. Wern,M. ?lweg?rd-Halvarsson,Y. ?rtengren Med. Chem. Commun. 2016 7 272 - 7. Progress on cocrystallization of poorly soluble NME's in the last decade
Parag Roy,Animesh Ghosh CrystEngComm 2020 22 6958 - 8. Repurposing drugs against the main protease of SARS-CoV-2: mechanism-based insights supported by available laboratory and clinical data
Sohini Chakraborti,Sneha Bheemireddy,Narayanaswamy Srinivasan Mol. Omics 2020 16 474 - 9. An injectable in situ lipid phase transition system for sustained delivery of dabigatran etexilate with low burst release
Xuanmiao Zhang,Mei Hu,Guangfei Wei,Mengdi Jia,Tao Gong,Ji Liu RSC Adv. 2017 7 56594 - 10. Transformation of a selective factor Xa inhibitor rivaroxaban into a dual factor Xa/thrombin inhibitor by modification of the morpholin-3-one moiety
Uro? Trstenjak,Janez Ila?,Danijel Kikelj Med. Chem. Commun. 2014 5 197
2850179284 
![N'-[(Z)-(2-氧萘基-1-亚甲基)甲基]吡啶-4-碳酰肼](http://hg.y866.cn/compound/lib/scimg/cas/150/796-42-9.png "N'-[(Z)-(2-氧萘基-1-亚甲基)甲基]吡啶-4-碳酰肼")
![4-[2,4-双(三氟甲基)苄氧基]-3-甲氧基苯甲醛](http://hg.y866.cn/compound/lib/scimg/cas/150/796844-14-9.png "4-[2,4-双(三氟甲基)苄氧基]-3-甲氧基苯甲醛")
